Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate.
暂无分享,去创建一个
Kozo Takayama | Mariko Morishita | Tsuneji Nagai | M. Morishita | T. Nagai | K. Takayama | Silvia Surini | Hidero Akiyama | Silvia Surini | Hidero Akiyama
[1] M. D. Blanco,et al. Chitosan microspheres in PLG films as devices for cytarabine release. , 2000, International journal of pharmaceutics.
[2] C. D. Gelatt,et al. Optimization by Simulated Annealing , 1983, Science.
[3] D J Berry,et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[4] K. Zhu,et al. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. , 2001, International journal of pharmaceutics.
[5] Robert D. Johnson,et al. Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.
[6] J. Heller. Polymers for controlled parenteral delivery of peptides and proteins , 1993 .
[7] H Schmidli,et al. Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] Y. M. Lee,et al. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[9] A. Badwan,et al. Immobilization of antibodies on alginate-chitosan beads. , 2000, International journal of pharmaceutics.
[10] K. Peh,et al. Investigation of interpolymer complexation between Carbopol and various grades of polyvinylpyrrolidone and effects on adhesion strength and swelling properties. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[11] D. Sandwell. BIHARMONIC SPLINE INTERPOLATION OF GEOS-3 AND SEASAT ALTIMETER DATA , 1987 .
[12] T. Nagai,et al. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate , 1990 .
[13] R. Khar,et al. INTERPOLYMER COMPLEXATION AND ITS EFFECT ON BIOADHESIVE STRENGTH AND DISSOLUTION CHARACTERISTICS OF BUCCAL DRUG DELIVERY YSTEMS , 1994 .
[14] J. Kh,et al. Advances in Pharmaceutical Sciences , 1982 .
[15] S. Howells,et al. Optimisation of radial basis function neural networks using biharmonic spline interpolation , 1998 .
[16] T Nagai,et al. Formula optimization based on artificial neural networks in transdermal drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[17] Hirofumi Takeuchi,et al. Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin , 2000, Pharmaceutical development and technology.
[18] T. Masada,et al. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.
[19] Christopher T. Rhodes,et al. Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .
[20] L. Illum,et al. Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.
[21] M. Singh,et al. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[22] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[23] M. Yonese,et al. Characteristics of complexes composed of sodium hyaluronate and bovine serum albumin. , 2000, Chemical & pharmaceutical bulletin.
[24] Kozo Takayama,et al. Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.
[25] Kozo Takayama,et al. Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .
[26] Vijay Kumar,et al. Interpolymer Complexation. II. Entrapment of Ibuprofen by In-Situ Complexation Between Polyvinyl Acetate Phthalate (PVAP) and Polyvinylpyrrolidone (PVP) and Development of a Chewable Tablet Formulation , 2001, Pharmaceutical development and technology (Print).
[27] T. Nagai,et al. Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. , 1989, Chemical & pharmaceutical bulletin.
[28] Roger Phan-Tan-Luu,et al. Pharmaceutical Experimental Design , 1998 .
[29] A. Münchow. Detiding Three-Dimensional Velocity Survey Data in Coastal Waters* , 2000 .
[30] N. Yui,et al. Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[31] V. Kumar,et al. Interpolymer complexation. I. Preparation and characterization of a polyvinyl acetate phthalate-polyvinylpyrrolidone (PVAP-PVP) complex. , 1999, International journal of pharmaceutics.